Dollar stores are the fastest-growing food retailers for homes in the U.S., according to a study published in the American Journal of Public Health ... Show more
https://trib.al/8YmPC3u
Dollar stores are the fastest-growing food retailers for homes in the U.S., according to a study published in the American Journal of Public Health ... Show more
https://trib.al/C7qMkru
Dollar stores are the fastest-growing food retailers for homes in the U.S., according to a study published in the American Journal of Public Health ... Show more
https://trib.al/guprPJ1
High-fashion French outlet Balenciaga has reportedly collaborated with American chip producer Lays to launch the Balenciaga x Lay’s handbag for a whopping ... Show more
https://www.jamaicaobserver.com/latest-news/balenciagas-lays-potato-chips-handbag-will-reportedly-sell-for-us1800/
The latest trend that has stunned many fashionistas is the '#Lays bag' from #Balenciaga . It was introduced by the the Spanish luxury label during #ParisFashionWeek ... Show more
https://bit.ly/3rB9zJ2
Quick Glance: Investigation against McKinsey in the US over involvement in the opioid industry
- A grand jury was established to examine evidence related to consulting for pharmaceutical companies involved in the addiction epidemic.
- McKinsey is under a criminal investigation in the US for its involvement with opioid manufacturers.
- Furthermore, federal prosecutors are looking into whether the company impeded justice through its actions as concerns about its work grew.
- According to a source, the US Department of Justice has been scrutinizing McKinsey's activities for several years, with a grand jury now set up in Virginia to review evidence.
Quick Glance: FDA approves Pfizer’s gene therapy for hemophilia B
- The FDA has approved Pfizer's first gene therapy drug for a rare inherited bleeding disorder.
- Beqvez, a unique gene therapy drug by Pfizer, has been approved for adults with moderate to severe hemophilia B.
- The drug enables patients to produce Factor IX themselves to prevent and control bleeding.
- Pfizer is competing with a similar treatment from CSL Behring and planning more gene therapies for various genetic disorders.
Quick Glance: Successful Vote of Confidence for Bayer CEO
- Bayer CEO Bill Anderson emerges victorious in a vote of confidence at his first annual general meeting despite a challenge from Deka Investment.
- Investors representing 91.69% of equity capital voted in favor of Anderson and his top management team.
- The voting process at German annual general meetings is symbolic and serves as a reflection of investor sentiment.
- Anderson defends the decision to suspend the company's breakup and pledges to focus on drug development and legal matters.
Quick Glance: Merck boosts 2024 profit outlook due to Keytruda sales
- Merck & Co. raises annual profit and revenue forecasts based on double-digit growth for the blockbuster cancer drug Keytruda.
- Sales for 2024 are estimated to be between $63.1 billion and $64.3 billion, an increase from the previous forecast.
- Keytruda recorded $6.95 billion in sales in the first quarter, a 20% increase from the previous year.
- Merck also saw strong growth with its vaccine Gardasil, the drug Vaxneuvance, and a successful acquisition of Harpoon Therapeutics in the first quarter of 2024.
Quick Glance: Warentest: Discount Cat Food Tops the List
- The number of cats in Germany has almost doubled, emphasizing the importance of quality food.
- Warentest examined 23 wet cat foods, focusing on nutritional content and adequacy.
- Out of the products tested, 16 received good ratings, while three performed poorly.
- The price-performance winner was Lidl's cat food, priced at only 0.37 euros per day.
Quick Glance: Sanofi Struggles with Profit Decline due to Competition and Currency Effects
- In the first quarter, Sanofi's operating income decreased by 14.7%, primarily due to currency effects and competitive pressures on their multiple sclerosis drug Aubagio, despite the increase in sales of the anti-inflammatory drug Dupixent.
- The company emphasized the forecast that adjusted earnings per share (EPS) for 2024 are expected to decrease by a low single-digit percentage, excluding currency fluctuations.
- During a media briefing, Finance chief Francois-Xavier Roger highlighted the impact of the decline in the Argentine Peso on first-quarter international sales.
- Since unexpectedly abandoning the 2025 margin targets last October under a plan to boost spending on drug development, CEO Paul Hudson has been working to restore investor confidence in the company's drug pipeline.
Kampagne Frühjahr-Sommer 2024 — CHANEL Brillen | CHANEL
‘CONDITIONS APPLY’ - Jamaica Observer
No more meat advertising at Dutch retailer | Beobachter
Quick Glance: Supermarket recalls own brand butter due to safety concerns
- Waitrose is urgently recalling its own brand butter due to potential contamination concerns.
- The impacted products are 500g blocks with the best before date of June 19, 2024.
- The potential contamination of the product poses a safety risk if consumed.
- Customers are advised to package the product and return it in-store for a refund.